The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

[1]  Tom Greene,et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) , 2008 .

[2]  Gerald F Watts,et al.  Carotid intima-medial thickness measured on multiple ultrasound frames: evaluation of a DICOM-based software system , 2007, Cardiovascular ultrasound.

[3]  P. Guarino,et al.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. , 2007, JAMA.

[4]  R. Draijer,et al.  Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. , 2007, The American journal of clinical nutrition.

[5]  A. Gómez de la Cámara,et al.  Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. , 2007, International journal of cardiology.

[6]  Xiping Xu,et al.  Efficacy of folic acid supplementation in stroke prevention: a meta-analysis , 2007, The Lancet.

[7]  F. Hsu,et al.  Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study , 2007, Circulation.

[8]  T. Matsuo,et al.  Uremic hyperhomocysteinemia: A randomized trial of folate treatment for the prevention of cardiovascular events , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.

[9]  C. Vrints,et al.  Effect of folic acid on endothelial function following acute myocardial infarction. , 2007, The American journal of cardiology.

[10]  Matthias W. Lorenz,et al.  Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.

[11]  K. Reynolds,et al.  Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. , 2006, JAMA.

[12]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[13]  E. Wiltshire,et al.  Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus , 2006, Pediatrics.

[14]  M. Bots,et al.  Effect of Folic Acid and Betaine Supplementation on Flow-Mediated Dilation: A Randomized, Controlled Study in Healthy Volunteers , 2006, PLoS clinical trials.

[15]  E. Ur,et al.  Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering , 2006, Vascular medicine.

[16]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[17]  J. McNeil,et al.  Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. , 2006, Journal of the American College of Cardiology.

[18]  J. Coombes,et al.  Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients. , 2006, Clinical nephrology.

[19]  A. A. Liakishev.  [Homocysteine lowering with folic acid and B vitamins in vascular disease]. , 2006, Kardiologiia.

[20]  A. Zwinderman,et al.  Secondary prevention with folic acid: results of the Goes extension study , 2005, Heart.

[21]  R. Vollandt,et al.  Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12. , 2005, Atherosclerosis.

[22]  L. Smeeth,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Homocysteine and Stroke: Evidence on a Causal Link from Mendelian Randomisation , 2022 .

[23]  J. Lekakis,et al.  Oral folic acid enhances endothelial function in patients with hypercholesterolemia receiving statins , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  H. Suryapranata,et al.  Folate therapy and in-stent restenosis after coronary stenting. , 2004, The New England journal of medicine.

[25]  C. Carlsson,et al.  Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults. , 2004, American heart journal.

[26]  J. Manson,et al.  The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants. , 2004, Journal of women's health.

[27]  H. Suryapranata,et al.  Folate Therapy and In-Stent Restenosis after Coronary Stenting , 2004 .

[28]  E. Wiltshire,et al.  Folic acid improves endothelial function in children and adolescents with type 1 diabetes. , 2004, The Journal of pediatrics.

[29]  J. Hung,et al.  Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects. , 2004, Clinical science.

[30]  T. Marwick,et al.  The relative importance of vascular structure and function in predicting cardiovascular events. , 2004, Journal of the American College of Cardiology.

[31]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[32]  J. Zehnder,et al.  Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[33]  M. Aksoy,et al.  Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia , 2003, Acta cardiologica.

[34]  R. Abbate,et al.  Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients , 2003, Transplantation.

[35]  D. Tsikas,et al.  ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. , 2003, Cardiovascular research.

[36]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[37]  E. Escobar,et al.  Hyperhomocysteinemia and Endothelial Function in Young Subjects: Effects of Vitamin Supplementation , 2002, Clinical cardiology.

[38]  O. Hess,et al.  Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. , 2002, JAMA.

[39]  Z. Varghese,et al.  Does Oral Folic Acid Lower Total Homocysteine Levels and Improve Endothelial Function in Children With Chronic Renal Failure? , 2002, Circulation.

[40]  C. Wolfe,et al.  The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke , 2002, Cerebrovascular Diseases.

[41]  J. Twisk,et al.  Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness: A 2-Year, Randomized, Placebo-Controlled Trial , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  D. Playford,et al.  Improved analysis of brachial artery ultrasound using a novel edge-detection software system. , 2001, Journal of applied physiology.

[43]  M. Landray,et al.  A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. , 2001, Journal of the American College of Cardiology.

[44]  E. Rocha.  [Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease]. , 2000, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[45]  J. Kooner,et al.  Improved Vascular Endothelial Function After Oral B Vitamins: An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine , 2000, Circulation.

[46]  M. Landray,et al.  Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? , 2000, Circulation.

[47]  K. Woo,et al.  Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. , 1999, Journal of the American College of Cardiology.

[48]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[49]  A. Keech,et al.  Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. , 1995, Circulation.

[50]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.